Frank X. Leonard, EVP, President, Novocure Oncology at NovoCure Ltd (NVCR), sold 2,519 shares at $16.03 ($40K) on 2024-03-01, disclosed to the SEC on 2024-03-05.
Seasonal sale ($40k) by EVP, President, Novocure Oncology — this insider has traded NVCR in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.03 | 1,679 | $27K | 66.7% |
| 2 | $16.01 | 840 | $13K | 33.3% |
| Total | $16.02 avg | 2,519 | $40K | 100% |
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |